儿童周期性呕吐综合征临床特征及氯丙嗪联合异丙嗪疗效分析
该回顾性队列研究分析了110例儿童周期性呕吐综合征(CVS)的临床特征,并比较急性发作期氯丙嗪联合异丙嗪肌内注射与昂丹司琼或奥美拉唑静脉滴注的疗效。结果显示氯丙嗪联合异丙嗪组呕吐持续时间更短(1(1,2)d 对 3(3,5)d,Z=6.69,P<0.01),且未观察到不良反应。
要点
- CVS患儿除呕吐外常伴厌食、腹痛等消化道症状及自主神经症状。
- 氯丙嗪联合异丙嗪肌内注射可缩短急性发作期呕吐持续时间。
- 该联合方案在研究中未观察到不良反应。
核心结论
- 儿童CVS可反复发作,除呕吐外常有其他消化道或自主神经紊乱相关症状。
- 氯丙嗪联合异丙嗪能更快缓解CVS患儿发作期症状且安全。
研究设计与样本
- 回顾性队列研究,纳入2015年1月至2025年1月广州医科大学附属妇女儿童医疗中心消化科诊断为CVS的110例患儿。
- 按发作期治疗方案分为异丙嗪+氯丙嗪组与昂丹司琼或奥美拉唑组,组间比较采用Mann-Whitney U检验。
主要发现
- 110例CVS患儿中男63例、女47例,发病年龄6.5(3.2,8.5)岁。
- 17.3%(19/110)患儿有诱发因素,饮食不当(8例)、感染(5例)较常见。
- 所有患儿均有呕吐,发作持续时间1~10 d,间歇期7 d至6个月。
- 消化道症状包括厌食110例(100%)、腹痛或腹部不适79例(71.8%)、腹泻2例(1.8%)。
- 21例出现自主神经症状(低热11例(10.0%)、面色苍白7例(6.4%)、血压升高2例(1.8%)、流涎1例(0.9%)),19例出现头痛或头晕(17.3%),13例存在心理疾病。
关键数值与推荐
- 急性发作期46例接受氯丙嗪联合异丙嗪肌内注射,呕吐持续时间1(1,2)d,未发生任何不良反应。
- 20例接受昂丹司琼或奥美拉唑静脉滴注,呕吐持续时间3(3,5)d。
- 氯丙嗪+异丙嗪组呕吐持续时间比昂丹司琼或奥美拉唑组更短,差异有统计学意义(Z=6.69,P<0.01)。
临床怎么用
- 对CVS急性发作期患儿,可考虑使用氯丙嗪联合异丙嗪肌内注射以缩短呕吐持续时间。
- 治疗期间需关注自主神经症状及心理疾病共病情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To analyze the clinical characteristics of cyclic vomiting syndrome (CVS) in children and to evaluate the efficacy of chlorpromazine combined with promethazine in treating acute episodes. Methods: This retrospective cohort study analyzed the clinical data of 110 pediatric patients diagnosed with CVS at the Department of Gastroenterology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University from January 2015 to January 2025. General information and clinical manifestations were summarized. Based on the treatment regimens administered during acute phases, patients were divided into the promethazine plus chlorpromazine group and the ondansetron or omeprazole group. The clinical efficacy of the two regimens was compared by Mann-Whitney U test. Results: Among the 110 children with CVS, there were 63 males and 47 females. The age of onset was 6.5 (3.2, 8.5) years. Predisposing factors were identified in 17.3% (19/110) of the children, with dietary indiscretion (8 cases) and infection (5 cases) being the most common. All children experienced vomiting, with episode durations ranging from 1 to 10 days and inter-episode intervals ranging from 7 days to 6 months. In addition to vomiting, gastrointestinal symptoms included anorexia in 110 cases (100%), abdominal pain or abdominal discomfort in 79 cases (71.8%), diarrhea in 2 cases (1.8%); 21 children exhibited autonomic nervous system symptoms, including low-grade fever in 11 cases (10.0%), pallor in 7 cases (6.4%), elevated blood pressure in 2 cases (1.8%), excessive salivation in 1 case (0.9%). Nervous system symptoms occurred in 19 cases, manifesting as headache or dizziness (17.3%). Psychological disorders were present in 13 children. During acute episodes, 46 children received intramuscular chlorpromazine combined with promethazine. Their vomiting duration was 1 (1, 2) d, and no adverse reactions were observed. In contrast, 20 children who received intravenous drip ondansetron or omeprazole had a vomiting duration of 3 (3, 5) d. The vomiting duration in the chlorpromazine plus promethazine group was significantly shorter than that in the ondansetron or omeprazole group (Z=6.69, P<0.01). Conclusions: CVS in children is characterized by recurrent episodes. Vomiting is frequently accompanied by other gastrointestinal or autonomic symptoms. For acute episodes, chlorpromazine combined with promethazine is an effective and safe treatment. 目的: 分析儿童周期性呕吐综合征(CVS)的临床特点,评估氯丙嗪+异丙嗪在CVS发作期的临床疗效及安全性。 方法: 回顾性队列研究。收集2015年1月至2025年1月于广州医科大学附属妇女儿童医疗中心消化科诊断为CVS的110例患儿的临床资料,对其一般资料、症状进行归纳总结;发作期治疗方案分为异丙嗪+氯丙嗪组、昂丹司琼或奥美拉唑组,比较两组治疗方案的治疗效果,组间比较采用Mann-Whitney U检验。 结果: 110例CVS患儿中男63例、女47例,发病年龄6.5(3.2,8.5)岁。17.3%的(19/110)患儿有诱发因素,饮食不当(8例)、感染(5例)较常见。所有患儿均有呕吐,发作持续时间为1~10 d,间歇期为7 d至6个月。消化道症状包括厌食110例(100%)、腹痛或腹部不适79例(71.8%)、腹泻2例(1.8%);21例患儿出现自主神经症状,包括低热11例(10.0%)、面色苍白7例(6.4%)、血压升高2例(1.8%)、流涎1例(0.9%);19例出现神经系统症状,表现为头痛或头晕(17.3%)。13例患儿存在心理疾病。急性发作期时,46例患儿接受氯丙嗪联合异丙嗪肌内注射后,呕吐持续时间为1(1,2)d,未发生任何不良反应;20例静脉滴注昂丹司琼或奥美拉唑后,呕吐持续时间3(3,5)d。氯丙嗪+异丙嗪组患儿呕吐持续时间比昂丹司琼或奥美拉唑组更短,差异有统计学意义(Z=6.69,P<0.01)。 结论: CVS可反复发作,除呕吐外常有其他消化道或自主神经紊乱相关症状,氯丙嗪联合异丙嗪更快缓解CVS患儿发作期症状且安全。.
引用
- Xiong LY, Chen PY, Xie J, et al. [Clinical characteristics of cyclic vomiting syndrome and the therapeutic efficacy of chlorpromazine combined with promethazine]. Zhonghua Er Ke Za Zhi. 2026. PMID: 41674423. doi:10.3760/cma.j.cn112140-20250601-00467
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。